Promoter Methylation Status and Protein Expression of BRCA2 in Patients with Epithelial Ovarian Cancer
Background: Ovarian cancer is the leading cause of death among gynecological cancers. Changes in the methylation of BRCA1 and BRCA2 may be an effective mechanism for breast and ovarian cancer. This study evaluates the protein expression and methylation status of BRCA2 in Iranian patients.Methods: We...
Main Authors: | Ahmad Shabanizadeh, Hajar Dahim, Reza Salahshoor, Zahra Taghipour, Mohammad Mohsen Taghavi, Hamidreza Gafarineveh, Bahram Eslami, Zahra Babazadeh, Farangis Fatehi |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2013-01-01
|
Series: | Middle East Journal of Cancer |
Subjects: | |
Online Access: | http://mejc.sums.ac.ir/index.php/mejc/article/view/138/219 |
Similar Items
-
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
by: Roshni D. Kalachand, et al.
Published: (2020-09-01) -
The BRCA Gene in Epithelial Ovarian Cancer
by: Luisa Sánchez-Lorenzo, et al.
Published: (2022-02-01) -
Genetic Changes in Ovarian Cancer
by: Kar-San Ling, et al.
Published: (2005-09-01) -
Comparative Investigation of DAL-1 Tumor Suppressor Protein Expression in Cancerous and Normal Ovarian Specimens
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2013-10-01) -
<i>BECN1</i> and <i>BRCA1</i> Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis
by: Amreen Salwa, et al.
Published: (2021-02-01)